Similar Search Results

Auswirkungen des Brexits auf die deutsche Pharmaindustrie : Relevanz des Vereinigten Königreichs für pharmazeutische Unternehmen in Deutschland

Kirchhoff, Jasmina - 2019

vor allem die Pharmaindustrie wie kaum eine andere Branche in Deutschland. Mit Blick auf die ökonomischen Verflechtungen … der deutschen und der britischen Pharmain-dustrie bietet der Brexit für den deutschen Pharmastandort aber nicht nur … werden. Für die deutsche Pharmaindustrie kann eine Neujustierung der Vertriebskanäle aber aufgrund der geringen Abhängigkeit …

Persistent link: https://www.econbiz.de/10012107254

Risk and reward in the orphan drug industry

Lo, Andrew W.; Thakor, Richard T. - 2018

Thanks to a combination of scientific advances and economic incentives, the development of therapeutics to treat rare or “orphan” diseases has grown dramatically in recent years. With the advent of FDA-approved gene therapies and the promise of gene editing, many experts believe we are at an...

Persistent link: https://www.econbiz.de/10011942396

The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013

Lichtenberg, Frank R. - In: Latin American economic review : LAER ; official … 26 (2017), pp. 1-22

I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003–2013, by investigating whether there were larger declines in the age-standardized mortality rate of cancer sites (breast, lung, colon, etc.) that were subject to more pharmaceutical...

Persistent link: https://www.econbiz.de/10011885726

Common ownership and market entry : evidence from the pharmaceutical industry

Newham, Melissa; Seldeslachts, Jo; Banal-Estañol, Albert - 2018

Common ownership - where two firms are at least partially owned by the same investor - and its impact on product market outcomes has recently drawn a lot of attention from scholars and practitioners alike. Theoretical and empirical researchsuggests that common ownership can lead to higher...

Persistent link: https://www.econbiz.de/10011865436

Beschäftigungsstruktur der europäischen Pharmaindustrie : ein Indikator für die Attraktivität eines Standorts?

Diel, Anastasia; Kirchhoff, Jasmina - 2020

In der Diskussion um die Sicherstellung einer bedarfsgerechten Arzneimittelversorgung in Deutschland steht auch die Frage im Raum, wie die Forschungs- und Produktionsstandorte pharmazeutischer Unternehmen vor Ort gestärkt werden können. Die Kriterien, nach denen Unternehmen ihre...

Persistent link: https://www.econbiz.de/10012151049

Common ownership and market entry : evidence from the pharmaceutical industry

Newham, Melissa; Seldeslachts, Jo; Banal-Estañol, Albert - 2019 - This version: November 13, 2019

Common ownership - where two firms are partially owned by the same investor - and its impact on product markets has recently drawn attention. This paper focuses on implications for entry. We consider the entry decisions of generic pharmaceutical firms into drug markets opened up by the end of...

Persistent link: https://www.econbiz.de/10012123288

Common ownership and market entry : evidence from the pharmaceutical industry

Newham, Melissa; Seldeslachts, Jo; Banal-Estañol, Albert - 2018 - This version: September 5, 2018

Common ownership - where two firms are at least partially owned by the same investor - and its impact on product market outcomes has recently drawn attention from scholars and practitioners. Previous research links common ownership with higher prices. This paper focuses on implications for...

Persistent link: https://www.econbiz.de/10012041144

Have pharmaceutical R&D project success rates decreased? : a critical review and new empirical results

Backfisch, Martin - 2017 - Version: 30 October 2017

In the context of the ongoing debate about an innovation crisis in the pharmaceutical industry, we study the success rates of pharmaceutical R&D projects as a measure of innovative productivity. The empirical literature suggests success rates have been decreasing during recent decades. We...

Persistent link: https://www.econbiz.de/10011773501

Die Rolle des Staates in der Impfstoffproduktion : technologische Restriktionen und ökonomische Ableitungen

Kirchhoff, Jasmina - 2021

Die Bundesregierung und die Europäische Kommission mussten in den letzten Wochen viel Kritik bezüglich ihrer Impfstoffbeschaffungsstrategie zur Eindämmung der Corona-Pandemie einstecken. Vor dem Hintergrund zu schleppend erscheinender Impfstofflieferungen und der zunehmenden Gefahr durch die...

Persistent link: https://www.econbiz.de/10012434819

Extra costs of integrity : pharmacy markups and generic substitution in Finland

Izhak, Olena - 2019

I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data covering all prescriptions of three popular antidepressants. I find that one euro increase in the total...

Persistent link: https://www.econbiz.de/10011954334